T cell receptor expression can switch on and off at a posttranslational level

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• The SUP-T13 cell line, used in T-acute lymphocytic leukemia research, exhibits heterogeneity with both T-cell receptor (TCR)/CD3 positive and negative cells.
• Individual SUP-T13 cells demonstrate spontaneous and reversible switching of surface TCR/CD3 expression.

Purpose of the Study:

• To investigate the mechanism behind the dynamic regulation of TCR/CD3 expression in SUP-T13 cells.
• To determine if the observed switching is due to genetic mutation or a regulatory process.
• To explore the implications of this phenomenon for T-cell leukemia therapies.

Main Methods:

• Single-cell cloning and culturing of SUP-T13 cells.
• Analysis of TCR/CD3 expression in parental and cloned cell populations.
• Intracellular protein localization studies using techniques like two-dimensional electrophoresis.
• Assessment of other cell surface glycoprotein expression.

Main Results:

• SUP-T13 cells exhibit a high rate of spontaneous TCR/CD3 expression switching (approx. 10^-2/cell/generation) in both directions.
• Reversion to the original expression state occurs at similar rates, ruling out spontaneous mutation as the primary cause.
• TCR/CD3 proteins are present intracellularly in negative cells, associate correctly, and show no structural abnormalities, but accumulate excessively.
• Other cell surface glycoproteins are unaffected, indicating specific regulation of the TCR/CD3 complex.

Conclusions:

• TCR/CD3 expression regulation in SUP-T13 cells occurs at a post-translational level.
• Further research into this mechanism could identify novel proteins involved in TCR/CD3 processing and transport.
• The plasticity of TCR/CD3 expression may pose challenges for TCR-targeted therapies in T-cell leukemias.